Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Current Liabilities (2023 - 2025)

Cannabis Bioscience International Holdings' Total Current Liabilities history spans 3 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 30.15% year-over-year to $1.1 million; the TTM value through Nov 2025 reached $1.1 million, up 30.15%, while the annual FY2025 figure was $945963.0, 7.26% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $1.1 million at Cannabis Bioscience International Holdings, up from $1.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.1 million in Q4 2025 and bottomed at $385547.0 in Q2 2023.
  • The 3-year median for Total Current Liabilities is $877291.5 (2024), against an average of $852110.0.
  • The largest annual shift saw Total Current Liabilities skyrocketed 128.74% in 2024 before it grew 7.26% in 2025.
  • A 3-year view of Total Current Liabilities shows it stood at $660307.0 in 2023, then soared by 32.16% to $872674.0 in 2024, then soared by 30.15% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Total Current Liabilities are $1.1 million (Q4 2025), $1.0 million (Q3 2025), and $945963.0 (Q2 2025).